[descriptive
link]
ATP
Organization |
The ATP
has grouped its R&D projects into two major activities,
as described below.
- Chemistry
and life sciences:
chemical processing, fuel, bulk processing, composites, agriculture,
condition-based maintenance, industrial physics, industrial
and manufacturing controls, industrial biotechnology, catalysis,
membrane technologies, tissue engineering, gene therapy,
DNA diagnostics, tissue culture, proteomics, nanotechnology,
biotechnology, immunology, cytokines, immunodiagnostics/laboratory
medicine, diagnostic instrumentation, therapeutics, drug
discovery technologies, drug delivery, inflammation, and
bone and joint diseases.
- Information
technology and electronics:
electronic commerce, advanced learning systems, information
systems for healthcare, micro- and nanosystems technology,
virtual reality, bioinformatics, biometrics and physical
security,intelligent manufacturing, photonics manufacturing,
microelectronics manufacturing infrastructure, supporting
technologies for lithography, advanced wireless communications,
and organic electronics.
In addition, ATP has an evaluation office, as described below.
- The Economic Assessment Office (EAO)
To assess whether ATP is meeting its mission, EAO employs statistical analyses, case study, econometric, survey and other methodological approaches to measure program effectiveness by evaluating the success of individual, clusters, and the portfolio of ATP projects in terms of inputs (the funding and staff necessary to move the R&D effort forward); outputs (project research results); outcomes (new products, processes, and services resulting from the innovation); and impacts (longer-run impacts on industries, society, and the economy).
|
ATP Advisory
Committee
The Advisory
Committee provides advice
on ATP programs, plans, and policies; reviews ATP's
efforts to assess the economic impact of the program; reports on
the general health of the program and its effectiveness in
achieving its legislatively mandated mission; and functions solely
as an advisory body, in accordance with the provisions of the Federal
Advisory Committee Act.
Date Created: April 2001
Last updated:
October 17, 2005
Return
to parent page.
|